腫瘍プロファイリングの市場規模、シェア、動向分析レポート：技法別、技術別、用途別、地域別、セグメント予測、2025年～2030年

腫瘍プロファイリング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の腫瘍プロファイリング市場規模は、2025年から2030年にかけてCAGR 10.4％で拡大し、2030年には217億米ドルに達すると予測されています。

がん検出におけるオミックス科学の応用研究の高まりが市場成長に影響を与えると予測されています。

バイオテクノロジーの技術的進歩により、代謝や遺伝子発現に関する深い洞察が可能になりました。これらにより、メタボロミクスやエピジェネティクスのような先端技術のがんスクリーニングや検出への応用が加速しています。このため、がん腫瘍/プロファイリング（CTP）技術の需要は、下流への応用の拡大とともに有利な成長が見込まれます。

がん腫瘍プロファイリングは、がんを検出し、腫瘍の病期、代謝、形態の変化を特定するためにさらに研究することができる潜在的な手順です。これは日常的な診断や治療の意思決定に役立ちます。腫瘍プロファイリングは、病気の重症度や個人のゲノムの蓄積に基づいて、特定の個人を対象とした治療法を開発する上で重要な意味を持っています。

NGSやin-situ hybridizationのような検出・シーケンス技術の強化は、がん腫瘍プロファイリング・プロセスの迅速化に役立ち、今後数年間で大きな牽引力を獲得すると推定されます。これらの高い採用率は、最小限のリソースとより高い精度で結果を得るための加速されたスピードに起因しています。

腫瘍プロファイリング市場レポートハイライト

• 個別化がん医療は、CTP採用で最も有利な応用分野となる見込み。
• がん細胞のゲノム、エピゲノム、メタボローム解析から得られる機能情報の用途の違いや相互依存性から、これらの技術セグメントは互いに連動して成長し、予測期間中に有利な成長を示すと予想されます。
• アジア太平洋地域は、新興経済諸国における有力企業の注力度の高まりとともに、主要経済諸国における様々な開発により、今後10年間で大幅な成長を遂げると予測されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 腫瘍プロファイリング市場の変数、動向、範囲

• 市場系統の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • 業界分析- ポーターのファイブフォース分析
  • PESTLE分析

第4章 腫瘍プロファイリング市場：技法別ビジネス分析

• 技法市場シェア、2024年および2030年
• 技法セグメントダッシュボード
• 市場規模、予測、動向分析（技法別、2018～2030年）
• ゲノミクス
• プロテオミクス
• メタボロミクス
• エピジェネティクス

第5章 腫瘍プロファイリング市場：技術別ビジネス分析

• 技術市場シェア、2024年と2030年
• 技術セグメントダッシュボード
• 市場規模、予測、動向分析（技術別、2018～2030年）
• シーケンシング技術
• インサイチューハイブリダイゼーション
• 免疫組織化学
• 定量PCR
• マイクロアレイ

第6章 腫瘍プロファイリング市場：用途別ビジネス分析

• 用途市場シェア、2024年および2030年
• 用途セグメントダッシュボード
• 市場規模、予測、動向分析（用途別、2018～2030年）
• 個別化がん医療
• 腫瘍診断
• 調査

第7章 腫瘍プロファイリング市場：地域別推定・動向分析

• 地域別市場シェア分析、2024年および2030年
• 地域市場ダッシュボード
• 市場規模と予測動向分析、2018年から2030年まで：
• 北米
  • 国別、2018年～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 国別、2018年～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • デンマーク
  • スウェーデン
• アジア太平洋
  • 国別、2018年～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • 国別、2018年～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 国別、2018年～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参入企業概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/リスト
  • Illumina Inc.
  • Qiagen NV
  • Exact Sciences Corporation
  • NeoGenomics Laboratories
  • Oxford Gene Technology IP Limited
  • Bruker Spatial Biology, Inc.
  • GenomeDX
  • Guardant Health
  • Foundation Medicine, Inc.

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. Global tumor profiling market, by region, 2018 - 2030 (USD Million)
• Table 4. Global tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 5. Global tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 6. Global tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 7. North America tumor profiling market, by country, 2018 - 2030 (USD Million)
• Table 8. North America tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 9. North America tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 10. North America tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 11. U.S. tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 12. U.S. tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 13. U.S. Tumor Profiling market, by application, 2018 - 2030 (USD Million)
• Table 14. Canada tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 15. Canada tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 16. Canada tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 17. Mexico tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 18. Mexico tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 19. Mexico tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 20. Europe tumor profiling market, by country, 2018 - 2030 (USD Million)
• Table 21. Europe tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 22. Europe tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 23. Europe tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 24. UK tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 25. UK tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 26. UK tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 27. Germany tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 28. Germany tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 29. Germany tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 30. France tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 31. France tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 32. France tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 33. Italy tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 34. Italy tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 35. Italy tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 36. Spain tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 37. Spain tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 38. Spain tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 39. Norway tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 40. Norway tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 41. Norway tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 42. Denmark tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 43. Denmark tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 44. Denmark tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 45. Sweden tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 46. Sweden tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 47. Sweden tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 48. Asia Pacific tumor profiling market, by country, 2018 - 2030 (USD Million)
• Table 49. Asia Pacific tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 50. Asia Pacific tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 51. Asia Pacific tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 52. Japan tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 53. Japan tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 54. Japan tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 55. China tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 56. China tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 57. China tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 58. India tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 59. India tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 60. India tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 61. Australia tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 62. Australia tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 63. Australia tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 64. South Korea tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 65. South Korea tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 66. South Korea tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 67. Thailand tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 68. Thailand tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 69. Thailand tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 70. Latin America tumor profiling market, by country, 2018 - 2030 (USD Million)
• Table 71. Latin America tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 72. Latin America tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 73. Latin America tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 74. Brazil tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 75. Brazil tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 76. Brazil tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 77. Argentina tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 78. Argentina tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 79. Argentina tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 80. Middle East & Africa tumor profiling market, by country, 2018 - 2030 (USD Million)
• Table 81. Middle East & Africa tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 82. Middle East & Africa tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 83. Middle East & Africa tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 84. South Africa tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 85. South Africa tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 86. South Africa tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 87. Saudi Arabia tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 88. Saudi Arabia tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 89. Saudi Arabia tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 90. UAE tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 91. UAE tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 92. UAE tumor profiling market, by application, 2018 - 2030 (USD Million)
• Table 93. Kuwait tumor profiling market, by technique, 2018 - 2030 (USD Million)
• Table 94. Kuwait tumor profiling market, by technology, 2018 - 2030 (USD Million)
• Table 95. Kuwait tumor profiling market, by application, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Tumor profiling market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Technique, technology and application outlook (USD Million)
• Fig. 10 Competitive landscape
• Fig. 11 Tumor profiling market dynamics
• Fig. 12 Tumor profiling market: Porter's five forces analysis
• Fig. 13 Tumor profiling market: PESTLE analysis
• Fig. 14 Tumor profiling market: Technique segment dashboard
• Fig. 15 Tumor profiling market: Technique market share analysis, 2024 & 2030
• Fig. 16 Genomics market, 2018 - 2030 (USD Million)
• Fig. 17 Proteomics market, 2018 - 2030 (USD Million)
• Fig. 18 Metabolomics market, 2018 - 2030 (USD Million)
• Fig. 19 Epigenetics market, 2018 - 2030 (USD Million)
• Fig. 20 Tumor profiling market: Technology segment dashboard
• Fig. 21 Tumor profiling market: Technology market share analysis, 2024 & 2030
• Fig. 22 Sequencing techniques market, 2018 - 2030 (USD Million)
• Fig. 23 In Situ hybridization market, 2018 - 2030 (USD Million)
• Fig. 24 Immunohistochemistry market, 2018 - 2030 (USD Million)
• Fig. 25 qPCR market, 2018 - 2030 (USD Million)
• Fig. 26 Microarray market, 2018 - 2030 (USD Million)
• Fig. 27 Tumor profiling market: Application segment dashboard
• Fig. 28 Tumor profiling market: Application market share analysis, 2024 & 2030
• Fig. 29 Personalized cancer medicine market, 2018 - 2030 (USD Million)
• Fig. 30 Oncological diagnostics market, 2018 - 2030 (USD Million)
• Fig. 31 Research market, 2018 - 2030 (USD Million)
• Fig. 32 Tumor profiling market revenue, by region
• Fig. 33 Regional marketplace: Key takeaways
• Fig. 34 Regional marketplace: Key takeaways
• Fig. 35 North America tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 36 U.S. country dynamics
• Fig. 37 U.S. tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 38 Canada country dynamics
• Fig. 39 Canada tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 40 Mexico country dynamics
• Fig. 41 Mexico tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 42 Europe tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 43 UK country dynamics
• Fig. 44 UK tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 45 Germany country dynamics
• Fig. 46 Germany tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 47 France country dynamics
• Fig. 48 France tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 49 Italy country dynamics
• Fig. 50 Italy tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 51 Spain country dynamics
• Fig. 52 Spain tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 53 Norway country dynamics
• Fig. 54 Norway tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 55 Sweden country dynamics
• Fig. 56 Sweden tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 57 Denmark country dynamics
• Fig. 58 Denmark tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 59 Asia Pacific tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 60 Japan country dynamics
• Fig. 61 Japan tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 62 China country dynamics
• Fig. 63 China tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 64 India country dynamics
• Fig. 65 India tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 66 Australia country dynamics
• Fig. 67 Australia tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 68 South Korea country dynamics
• Fig. 69 South Korea tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 70 Thailand country dynamics
• Fig. 71 Thailand tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 72 Latin America tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 73 Brazil country dynamics
• Fig. 74 Brazil tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 75 Argentina country dynamics
• Fig. 76 Argentina tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 77 MEA tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 78 South Africa country dynamics
• Fig. 79 South Africa tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 80 Saudi Arabia country dynamics
• Fig. 81 Saudi Arabia tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 82 UAE country dynamics
• Fig. 83 UAE tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 84 Kuwait country dynamics
• Fig. 85 Kuwait tumor profiling market, 2018 - 2030 (USD Million)
• Fig. 86 Company categorization
• Fig. 87 Company market position analysis
• Fig. 88 Strategic framework

Tumor Profiling Market Growth & Trends:

The global tumor profiling market size is expected to reach USD 21.7 billion by 2030, expanding at a CAGR of 10.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising research in the application of omics sciences in cancer detection is anticipated to influence market growth.

Technological advances in biotechnology have allowed for deeper insights into metabolism and gene expression. These have accelerated the application of advanced techniques such as metabolomics and epigenetics in cancer screening and detection. Thus, demand for cancer tumor/profiling (CTP) techniques is anticipated to witness lucrative growth with the expansion of downstream applications.

Cancer tumor profiling is a potential procedure through which cancer can be detected and studied further to identify the stage, metabolism, and changes in morphology of the tumor. This aids in routine diagnostics as well as therapeutic decision-making. Tumor profiling has significant importance in developing therapies aimed at a specific individual, based on the severity of ailment and genomic build up of the individual.

Enhanced detection and sequencing techniques such as NGS and in-situ hybridization can help speed up the cancer tumor profiling process and are estimated to gain much traction over the coming years. Their high adoption is attributive to accelerated speed in gaining results with minimum resources and greater accuracy.

Tumor Profiling Market Report Highlights:

• Personalized cancer medicine is expected to be the most lucrative application segment for CTP adoption.
• Owing to difference in usage of and interdependency of functional information from genomic, epigenomic, and metabolomic analysis of cancer cells, it can be expected that these technology segments will grow in tandem with each other and exhibit lucrative growth over the forecast years
• Asia Pacific is projected to witness substantial growth over the next decade owing to various developments across major economies, with increased focus of dominant players in emerging economies as well

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technique
  • 1.2.2. Technology
  • 1.2.3. Application
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Tumor Profiling Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Tumor Profiling Market: Technique Business Analysis

• 4.1. Technique Market Share, 2024 & 2030
• 4.2. Technique Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Technique, 2018 to 2030 (USD Million)
• 4.4. Genomics
  • 4.4.1. Genomics Market, 2018 - 2030 (USD Million)
• 4.5. Proteomics
  • 4.5.1. Proteomics Market, 2018 - 2030 (USD Million)
• 4.6. Metabolomics
  • 4.6.1. Metabolomics Market, 2018 - 2030 (USD Million)
• 4.7. Epigenetics
  • 4.7.1. Epigenetics Market, 2018 - 2030 (USD Million)

Chapter 5. Tumor Profiling Market: Technology Business Analysis

• 5.1. Technology Market Share, 2024 & 2030
• 5.2. Technology Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 5.4. Sequencing Techniques
  • 5.4.1. Sequencing Techniques Market, 2018 - 2030 (USD Million)
• 5.5. In Situ Hybridization
  • 5.5.1. In Situ Hybridization Market, 2018 - 2030 (USD Million)
• 5.6. Immunohistochemistry
  • 5.6.1. Immunohistochemistry Market, 2018 - 2030 (USD Million)
• 5.7. qPCR
  • 5.7.1. qPCR Market, 2018 - 2030 (USD Million)
• 5.8. Microarray
  • 5.8.1. Microarray Market, 2018 - 2030 (USD Million)

Chapter 6. Tumor Profiling Market: Application Business Analysis

• 6.1. Application Market Share, 2024 & 2030
• 6.2. Application Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Personalized Cancer Medicine
  • 6.4.1. Personalized Cancer Medicine Market, 2018 - 2030 (USD Million)
• 6.5. Oncological Diagnostics
  • 6.5.1. Oncological Diagnostics Market, 2018 - 2030 (USD Million)
• 6.6. Research
  • 6.6.1. Research Market, 2018 - 2030 (USD Million)

Chapter 7. Tumor Profiling Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 7.4. North America
  • 7.4.1. North America Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Regulatory Framework
    • 7.4.2.3. Competitive Insights
    • 7.4.2.4. U.S. Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Regulatory Framework
    • 7.4.3.3. Competitive Insights
    • 7.4.3.4. Canada Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Regulatory Framework
    • 7.4.4.3. Competitive Insights
    • 7.4.4.4. Mexico Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Insights
    • 7.5.2.4. UK Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Insights
    • 7.5.3.4. Germany Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Insights
    • 7.5.4.4. France Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Regulatory Framework
    • 7.5.5.3. Competitive Insights
    • 7.5.5.4. Italy Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Regulatory Framework
    • 7.5.6.3. Competitive Insights
    • 7.5.6.4. Spain Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Norway
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Regulatory Framework
    • 7.5.7.3. Competitive Insights
    • 7.5.7.4. Norway Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Denmark
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Regulatory Framework
    • 7.5.8.3. Competitive Insights
    • 7.5.8.4. Denmark Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Sweden
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Regulatory Framework
    • 7.5.9.3. Competitive Insights
    • 7.5.9.4. Sweden Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Insights
    • 7.6.2.4. Japan Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Insights
    • 7.6.3.4. China Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Insights
    • 7.6.4.4. India Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Insights
    • 7.6.5.4. South Korea Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Insights
    • 7.6.6.4. Australia Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Insights
    • 7.6.7.4. Thailand Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Insights
    • 7.7.2.4. Brazil Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Insights
    • 7.7.3.4. Argentina Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA Tumor Profiling Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Insights
    • 7.8.2.4. South Africa Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Regulatory Framework
    • 7.8.3.3. Competitive Insights
    • 7.8.3.4. Saudi Arabia Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Regulatory Framework
    • 7.8.4.3. Competitive Insights
    • 7.8.4.4. UAE Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Regulatory Framework
    • 7.8.5.3. Competitive Insights
    • 7.8.5.4. Kuwait Tumor Profiling Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Illumina Inc.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Qiagen N.V.
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Exact Sciences Corporation
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. NeoGenomics Laboratories
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Oxford Gene Technology IP Limited
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Bruker Spatial Biology, Inc.
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. GenomeDX
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Guardant Health
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Foundation Medicine, Inc.
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives